Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report

• Main Authors: Yu-Chien Lin (Author), Kuo-Chang Wen (Author), Pi-Lin Sung (Author), Yu-Ting Chou (Author), Phui-Ly Liew (Author), Lin-Yu Chen (Author), Rui-Lan Huang (Author), Hung-Cheng Lai (Author), Lu-Te Chang (Author)
• Format: Book
• Published: BMC, 2020-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Patients with ovarian clear cell carcinoma (OCCC) have a poor prognosis because they show low sensitivity to platinum-based chemotherapy. New treatments for refractory OCCC are urgently needed. Case presentation We present a patient with refractory OCCC in whom conventional chemo...